PKM and ovarian carcinoma: As shown in Table S2, in clear cell RCC and UCEC, the phosphorylation sites of PKM2 were mainly concentrated in the XP_006720633.1 while in NP_002645.3, PKM2 phosphorylation sites were fewer, especially in breast cancer and ovarian cancer.